Legendary biotech leader passes away, renewed tension around aducanumab, Merck’s rare defeat, and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.

For many of our readers, we wish you are...

Click to view original post